Scientific interest in cannabidiol has grown because the endocannabinoid system participates in many physiological processes. This does not mean CBD is a proven treatment for every condition mentioned in early studies.
Where is evidence more established?
Some pharmaceutical cannabidiol formulations have evidence and approval for specific epilepsy syndromes. In other areas—pain, anxiety, sleep, neurological symptoms and inflammation—results and evidence quality vary.
Areas frequently studied
- specific epilepsies;
- chronic and neuropathic pain;
- anxiety and sleep;
- multiple sclerosis and spasticity;
- Parkinson’s disease and other neurological symptoms;
- some symptoms associated with autism spectrum disorder.
Therapeutic potential is not the same as an automatic indication. Individual professional assessment remains essential.
Educational content. This information does not replace consultation, diagnosis or prescription by a qualified professional.